Stock listing
Kintor Pharmaceutical Ltd
Selected listing: KNTPF · OTC · USD · US
Kintor Pharmaceutical Ltd (OTC:KNTPF), Health Technology. Latest release Oct 2, 2026: Monthly Return of Equity Issuer on Movements in Securities for the month…
- Ticker
- OTC:KNTPF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Kintor Pharmaceutical Ltd
The company focuses on developing innovative therapies for various medical conditions. Kintor aims to advance its pipeline of drug candidates to address unmet medical needs.
Latest news from Kintor Pharmaceutical Ltd
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
INTERIM REPORT 2026
September 29, 2026
Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint
July 25, 2025
Kintor Pharmaceutical : Pharma Announces Publication of Phase Ib/II Data from GT90001 and Nivolumab Combination Therapy for Advanced HCC in BMC Medicine
October 27, 2023
Kintor Pharmaceutical : Pharma Announces the Approval of Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China
October 11, 2023
Research Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd company profile
View the public company page for Kintor Pharmaceutical Ltd on 6ix.
Kintor Pharmaceutical Ltd news
Read company news and market updates connected to Kintor Pharmaceutical Ltd.
Kintor Pharmaceutical Ltd investor events
Find investor webinars, events, and replay context for Kintor Pharmaceutical Ltd.